###begin article-title 0
Novel biphasic role for lymphocytes revealed during resolving inflammation
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 407 410 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 627 628 627 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 744 745 736 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 750 751 742 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 847 850 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1033 1036 1025 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
###xml 1037 1041 <span type="species:ncbi:10090">mice</span>
###xml 1330 1335 <span type="species:ncbi:9606">human</span>
Acute inflammation is traditionally described as the influx of polymorphonuclear leukocytes (PMNs) followed by monocyte-derived macrophages, leading to resolution. This is a classic view, and despite subpopulations of lymphocytes possessing innate immune-regulatory properties, seldom is their role in acute inflammation and its resolution discussed. To redress this we show, using lymphocyte-deficient RAG1-/- mice, that peritoneal T/B lymphocytes control PMN trafficking by regulating cytokine synthesis. Once inflammation ensues in normal mice, lymphocytes disappear in response to DP1 receptor activation by prostaglandin D2. However, upon resolution, lymphocytes repopulate the cavity comprising B1, natural killer (NK), gamma/delta T, CD4+/CD25+, and B2 cells. Repopulating lymphocytes are dispensable for resolution, as inflammation in RAG1-/- and wild-type mice resolve uniformly. However, repopulating lymphocytes are critical for modulating responses to superinfection. Thus, in chronic granulomatous disease using gp91phox-/- mice, not only is resolution delayed compared with wild-type, but there is a failure of lymphocyte re-appearance predisposing to exaggerated immune responses upon secondary challenge that is rescued by resolution-phase lymphocytes. In conclusion, as lymphocyte repopulation is also evident in human peritonitis, we hereby describe a transition in T/B cells from acute inflammation to resolution, with a central role in modulating the severity of early onset and orchestrating responses to secondary infection.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 285 286 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B1">1</xref></sup>
###xml 943 944 943 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 945 946 945 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 943 946 943 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref></sup>
###xml 958 959 958 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 960 961 960 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 958 961 958 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref></sup>
Inflammation is controlled by a balance of proinflammatory and antiinflammatory signals, resulting in the development of an immune response followed by temporally released proresolution factors that lead to inflammation switching off and injured tissues returning to normal physiology.1 In this setting, attention is traditionally placed on phagocytes such as polymorphonuclear leukocytes (PMNs) and monocyte-derived macrophages, with comparatively less weight place on the importance of lymphocytes in acute inflammation and its resolution. Given their roles in early defense to bacteria and viruses, innate-type lymphocytes including B1 cells merit further exploration for their potential roles in host defense and restorative physiology, as it is becoming clear that diminished innate lymphocyte function or enhanced lymphocyte death by apoptosis, for instance, has being postulated to play a central role in the pathogenesis of burn injury2,3 and sepsis,4,5 respectively
###end p 4
###begin p 5
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B6">6</xref></sup>
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 123 123 123 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8"/>
###xml 123 123 123 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9"/>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 122 126 122 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B7">7</xref><xref ref-type="bibr" rid="B8"/><xref ref-type="bibr" rid="B9"/>&#8211;<xref ref-type="bibr" rid="B10">10</xref></sup>
###xml 644 645 644 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 977 978 969 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 983 984 975 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1526 1527 1518 1519 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1528 1530 1520 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1528 1530 1520 1522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B11">11</xref></sup>
###xml 1615 1617 1603 1605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1615 1617 1603 1605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B12">12</xref></sup>
###xml 1765 1767 1745 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1765 1767 1745 1747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B13">13</xref></sup>
###xml 1831 1833 1811 1813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1834 1836 1814 1816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1831 1836 1811 1816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref></sup>
###xml 1088 1093 <span type="species:ncbi:9606">human</span>
###xml 1583 1588 <span type="species:ncbi:9606">human</span>
###xml 1751 1756 <span type="species:ncbi:9606">human</span>
One of the major impetuses for this current investigation stemmed from our previous observations6 and those made by others7-10 showing lymphocytes repopulating sites of tissue injury as inflammation abates, suggesting that lymphocytes might help to switch off acute inflammation. Investigating this possibility in experimental peritonitis, T and B lymphocytes, normal residents of the naive peritoneum, were found to regulate the severity of the early onset phase of acute inflammation by elaborating anti-inflammatory cytokines and dampening PMN influx. However, once PMNs begin to accumulate, resident lymphocytes disappear in response to PGD2 working through its DP1 receptor. As inflammation resolves, a unique profile of lymphocytes begin to repopulate the cavity. Repopulating lymphocytes, however, do not bring about resolution but replenish resolving tissues with the necessary cellular players (CD3, B1 cells, natural killer [NK] and gamma/delta T cells as well as CD4+/CD25+ T cells) to control future innate immune-mediated responses. We provide relevance of these findings to human health by showing the absence of repopulating lymphocytes in nonresolving inflammation, which predisposes to secondary infection, resulting in severe inflammatory responses. Although lymphocytes in adaptive immunity are well understood, their role in innate immunity and resolution is highlighted here, as is their functional control by lipid mediators, of which there is a growing body of evidence. For instance, in addition to PGD2,11 lipoxins and aspirin-triggered epi-lipoxins inhibit human T-cell TNFalpha secretion,12 while docosahexanoic acid-derived protectin D1 blocks T-cell migration and TNFalpha and IFNgamma secretion and promotes apoptosis in human T cells.13 Thus, from these current studies and those published by others,12,13 we highlight the regulatory role played by n-3 and n-6 polyunsaturated fatty acid metabolites on lymphocyte function during acute inflammation and its resolution.
###end p 5
###begin title 6
Methods
###end title 6
###begin title 7
###xml 46 51 <span type="species:ncbi:9606">human</span>
Animal maintenance, induction of inflammation human peritonitis sampling
###end title 7
###begin p 8
###xml 29 30 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 109 111 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B14">14</xref></sup>
###xml 951 953 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 954 956 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 951 956 943 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref></sup>
###xml 980 981 972 973 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 994 996 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 994 996 986 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B17">17</xref></sup>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 473 494 <span type="species:ncbi:1319">group B streptococcus</span>
###xml 496 499 <span type="species:ncbi:1319">GBS</span>
###xml 727 732 <span type="species:ncbi:9606">human</span>
###xml 824 832 <span type="species:ncbi:9606">patients</span>
Hematopoietic prostaglandin D2 (PGD2) synthase (hPGD2S) knockout mice were generated as previously described.14 All other animals were bred under standard conditions and maintained in a 12-hour/12-hour light/dark cycle at 22 (+/-1)degreesC and given food and tap water ad libitum in accordance with United Kingdom Home Office regulations. Peritonitis was induced by the intraperitoneal injection of either type A zymosan (1 mg for all experiments unless otherwise stated), group B streptococcus (GBS), or LPS (1 mg/kg; Sigma-Aldrich, St Louis, MO), and cells were enumerated by haemocytometer at time points stated in "Results" by sterile phosphate-buffered saline (PBS) washout. Ethical approval (P/03/136A) for collection of human peritonitis samples was obtained from St Bartholomew's and the Royal London Hospitals from patients with end-stage renal failure undergoing peritoneal dialysis. For pharmacologic rescue experiments, BW245C (DP1 agonist15,16) or 15(R)-15-methyl PGD2 (DP2 agonist17) in 100 muL of PBS (pH 7.2)/BSA 0.1% was injected at equal doses at 30 minutes prior to and after the zymosan.
###end p 8
###begin title 9
Trypsinization of peritoneal cavity
###end title 9
###begin p 10
###xml 65 69 <span type="species:ncbi:10090">mice</span>
To determining the fate of peritoneal T and B cells, cavities of mice bearing a 4-hour zymosan-induced peritonitis was lavaged with sterile PBS to remove accumulated inflammatory cells and edema. A total of 5 mL prewarmed 5% trypsin was then added to the peritoneal cavity for 10 minutes, followed by an equal volume complete medium to acquire cells adhered to the peritoneal lining/greater omental lymphoid organ. Cells were then analyzed for composition by fluorescence-activated cell sorter (FACS).
###end p 10
###begin title 11
FACS analysis and cytokine/chemokine analysis
###end title 11
###begin p 12
###xml 430 433 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
Cytokines were measured by enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions (eBioscience, San Diego, CA). FACS was carried out on a Becton Dickinson Facscalibur with data analyzed by CellQuest (BD, Franklin Lakes, NJ). Leukocytes were incubated with antibodies for 30 minutes to either CD3/CD19 (Serotec, Oxford, United Kingdom), B cells (Ly220; Serotec), CD5 (BD PharMingen, San Diego, CA), MAC-1/CD11b (BD PharMingen), NK and gamma/delta cells (gift from Dr T. Hussell, Kennedy Institute, London, United Kingdom), GR1 (BD PharMingen), or F4/80 (Caltag Laboratories, Burlingame, CA) using respective isotype antibodies as controls (Serotec) and compensated as appropriate for dual labeling. For apoptosis, cells were incubated with annexin V/propidium iodide (BD PharMingen) and analyzed on Becton Dickinson Facscalibur with data analyzed by CellQuest.
###end p 12
###begin title 13
Leukocyte separation and analysis
###end title 13
###begin p 14
###xml 333 337 325 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 543 544 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 577 581 569 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
###xml 1304 1308 <span type="species:ncbi:9913">calf</span>
###xml 1514 1517 <span type="species:ncbi:10116">rat</span>
###xml 1543 1548 <span type="species:ncbi:10090">mouse</span>
###xml 1653 1658 <span type="species:ncbi:10090">mouse</span>
###xml 1786 1789 <span type="species:ncbi:10116">rat</span>
###xml 1836 1841 <span type="species:ncbi:10090">mouse</span>
###xml 2074 2079 <span type="species:ncbi:9940">sheep</span>
###xml 2103 2106 <span type="species:ncbi:10116">rat</span>
Contents of resolving-phase peritoneal cavities of wild-type animals were isolated, and macrophages were separated from remaining lymphocytes by adherence to the bottom of 6-well tissue-culture plates. Nonadherent cells were removed and used to isolate T and B cells as well as NK and gamma/delta T cells for transfer back in to gp91phox knockout mice using FACS and relevant antibodies to confirm that their composition and ratios reflects that present in situ at resolution. Resolving-phase lymphocytes were enriched at a concentration of 106/mL and 0.5 mL injected into gp91phox knockout mice. In addition, one of the problems with identifying discrete populations of cells such as those found at sites of inflammation by FACS from a larger mixed cell population is that the fluorescence of one cell type after labeling with a fluorescent antibody may be masked by the natural fluorescence of others. In order to confirm the cell types identified using cell-surface antigen markers, peritoneal lymphocytes and macrophages were also isolated and put back into the FACS with their forward- and side-scatter signatures compared against specifically labeled cells. Thus, after lymphocytes were removed from 6-well plates, adherent cells, mainly macrophages, were eluted with Versene, washed with 2% fetal calf serum (FCS) in Hanks balanced salt solution (HBSS) and resuspended in Dulbecco modified Eagle medium (DMEM). These cells were further depleted of contaminant T and B cells using magnetic beads coated with rat monoclonal antibodies to mouse CD3 or B220 (Dynal Biotech, Paisley, United Kingdom). T and B lymphocytes were isolated using the Dynal mouse B-cell (or T-cell) negative isolation kit according to the manufacturer's instructions (Dynal Biotech). In brief, a mixture of rat monoclonal antibodies with specificity to all mouse non-B cells (or non-T cells when isolating T cells) cells were added to cell suspensions and incubated for 20 minutes at 4degreesC. Cells coated with the added monoclonal antibodies were then removed with magnetic beads coated with sheep polyclonal antibody to rat Ig. Purity of the cells were regularly greater than 95%.
###end p 14
###begin title 15
Bacterial culturing
###end title 15
###begin p 16
###xml 126 129 120 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 154 155 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 281 282 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 394 395 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 13 16 <span type="species:ncbi:1319">GBS</span>
###xml 231 235 <span type="species:ncbi:10090">Mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
The clinical GBS isolate, NCTC10/84 (serotype V) was grown in Todd Hewitt Broth (THB) without agitation at 37degreesC to an OD600 of 0.4, equivalent to 108 cfu/mL. Bacteria collected by centrifugation were washed with sterile PBS. Mice were inoculated intraperitoneally with 3 x 107 cfu NCTC in 30 muL PBS. For survival experiments, mice were inoculated by intraperitoneal injection with 5 x 107 cfu NCTC in 0.3 mL PBS.
###end p 16
###begin title 17
Results
###end title 17
###begin title 18
Biphasic trafficking of lymphocytes during acute inflammation
###end title 18
###begin p 19
###xml 2 3 2 3 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B6">6</xref></sup>
###xml 14 15 14 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 15 15 15 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8"/>
###xml 15 15 15 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9"/>
###xml 16 18 16 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 14 18 14 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B7">7</xref><xref ref-type="bibr" rid="B8"/><xref ref-type="bibr" rid="B9"/>&#8211;<xref ref-type="bibr" rid="B10">10</xref></sup>
###xml 349 357 349 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 392 400 392 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 553 554 553 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 765 773 765 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1215 1216 1215 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1224 1225 1224 1225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1274 1275 1274 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1280 1281 1280 1281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1318 1326 1310 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1512 1520 1504 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1560 1563 1552 1555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 1567 1568 1559 1560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1574 1577 1566 1569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 1638 1642 1630 1634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1648 1649 1640 1641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1784 1792 1776 1784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1824 1825 1816 1817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1830 1831 1822 1823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1892 1900 1876 1884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1984 1992 1968 1976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 2092 2097 2076 2081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Blood</italic>
###xml 2320 2328 2304 2312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 2674 2682 2658 2666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 270 275 <span type="species:ncbi:9606">human</span>
###xml 433 441 <span type="species:ncbi:9606">patients</span>
###xml 455 463 <span type="species:ncbi:9606">patients</span>
###xml 745 751 <span type="species:ncbi:10090">murine</span>
###xml 1055 1061 <span type="species:ncbi:10090">murine</span>
###xml 1569 1572 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 1643 1646 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 1953 1956 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
We6 and others7-10 have previously observed lymphocytes repopulating sites of injury as inflammation resolves, but without attributing a functional relevance to their reappearance. Trafficking of lymphocytes during resolution is apparent in inflammation associated with human chronic ambulatory peritoneal dialysis where, as inflammation decreases (Figure 1A,B), lymphocyte numbers increase (Figure 1C). Clinical assessment of these patients was based on patients presenting with abdominal pain, cloudy dialysate, and leukocyte count of more than 100/mm3. In all cases, peritonitis resolved by day 5 as determined by the appearance of a clear dialysate and abatement of abdominal symptoms. Similar results were evident in resolving experimental murine peritonitis (Figure 1D). Experiments were therefore carried out to establish the role these cells play in innate immune-mediated inflammation by characterizing, in the first instance, the profile of lymphocyte populations throughout the time course of an acute zymosan-induced peritonitis. In the naive murine peritoneum (0 hours), lymphocytes constitute about 50% of the total cell population, with the remaining being resident macrophages. Of the CD3 cells, CD4+ and CD8+ cells were found as well as lower numbers of CD4+/CD25+, gamma/delta T cells, and NK cells (Figure 1E-J). However, the majority of lymphocytes in the naive cavity are B cells constituting about 70% to 80% of the total lymphocyte population labeling positively for CD19 as well as B220 (Figure 1K). Of these B cells, about 80% are B220low/CD5+/MAC-1low, indicative of a B1 phenotype, with the remainder being B220high/MAC-1- B2 cells. As inflammation initiates (1-4 hours), T and B cells disappear but repopulate the peritoneum again between 12 and 24 hours (Figure 1D). Notably, there were more CD4+/CD25+, gamma/delta T cells, and NK cells found during resolution (Figure 1H-J) as well as B1 cells expressing higher levels of MAC-1 than in the naive state (Figure 1K), collectively referred to hereafter as resolution-phase lymphocytes. Figure S6 (available on the Blood website; see the Supplemental Materials link at the top of the online article) shows FACS analysis of lymphocyte cell-surface labeling. As inflammation peaks between 6 and 12 hours in this model and subsequently resolves (Figure 1D), it is argued that lymphocytes repopulate the peritoneum during or just after resolution occurs. Indeed, experimentally enhancing the severity of the inflammatory response within the peritoneum by injecting 3 separate doses of zymosan (0.1, 1.0, and 10 mg), therefore prolonging resolution, is associated with reduced lymphocyte repopulation (Figure 1L). Whether this is a delay or suppression is unclear at this stage. However, from the data presented here, we suggest that lymphocytes repopulate sites of inflammation once resolution occurs. Therefore, this questions what controls lymphocyte influx, which we suggest may be factors released by stromal and/or hematopoietic cells once restitution processes are under way. If so, lymphocyte repopulation is an active process and, until resolution occurs, lymphocyte repopulation is suppressed. Thus, from these experiments we show a shift in lymphocyte populations from the naive to a resolving state constituting more innate-type lymphocytes as well as a different phenotype of B1 cells.
###end p 19
###begin p 20
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Biphasic trafficking of lymphocytes during acute inflammation.</bold>
###xml 523 524 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 641 642 633 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 977 978 969 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 990 991 980 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1071 1072 1059 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 69 77 <span type="species:ncbi:9606">Patients</span>
###xml 278 284 <span type="species:ncbi:10090">murine</span>
###xml 636 639 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
Biphasic trafficking of lymphocytes during acute inflammation. (A-C) Patients undergoing chronic ambulatory peritoneal dialysis and who developed peritonitis that resolved were found to have lymphocytes at the time of recovery of clinical symptoms. Pursuing this observation in murine zymosan-induced peritonitis (D), T and B cells native to the naive peritoneal cavity were found to disappear within hours of stimulus injection. Once inflammation resolves, lymphocytes repopulate the peritoneum but comprise more (E-J) CD4+/CD25 and gamma/delta T cells as well as NK cells, than is present in the naive cavity (0 hours) as well as (K) MAC-1+ B cells. (L) Experimentally enhancing the severity of the inflammatory response within the peritoneum by injecting 3 separate doses of zymosan (0.1, 1.0, and 10 mg) prolonged resolution and delayed lymphocyte repopulation (72 hours), suggesting that lymphocytes repopulate only after resolution occurs. n = 6 to 8 animals per group; *P </= .05; **P </= .01, as determined by analysis of variance (ANOVA), followed by Bonferroni t test, with data expressed as means plus or minus SEM.
###end p 20
###begin title 21
Lymphocytes are dispensable for resolution but mediate responses to superinfection
###end title 21
###begin p 22
###xml 134 137 134 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 233 241 233 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 286 294 286 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 420 428 416 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 480 483 476 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 530 538 526 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 872 875 868 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1102 1110 1098 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1366 1369 1362 1365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1527 1535 1523 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1612 1615 1608 1611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1617 1625 1613 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1719 1727 1715 1723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
###xml 890 894 <span type="species:ncbi:10090">mice</span>
###xml 934 937 <span type="species:ncbi:1319">GBS</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
###xml 1234 1237 <span type="species:ncbi:1319">GBS</span>
###xml 1353 1356 <span type="species:ncbi:1319">GBS</span>
###xml 1370 1374 <span type="species:ncbi:10090">mice</span>
###xml 1497 1501 <span type="species:ncbi:10090">mice</span>
###xml 1596 1599 <span type="species:ncbi:1319">GBS</span>
To examine the role of lymphocytes in acute inflammation, zymosan was injected into the peritoneal cavity of lymphocyte-deficient RAG1-/- mice. Inflammation at onset was greatly exaggerated in these animals, twice that in wild-type (Figure 2A), with the principal cell type being PMNs (Figure 2B). This exaggerated response in RAG1 knockout mice was associated with decreased exudate IL-10 and elevated TNFalpha levels (Figure 2C). Surprisingly, inflammation in wild-type and RAG1-/- mice resolved uniformly from 24 hours onward (Figure 2A,B), suggesting that lymphocytes have no role in switching off acute inflammation and that regardless of how many PMNs traffic to sites of tissue injury, resolution pathways are sufficiently adept at dealing with their disposal. Pursuing the idea that lymphocytes may protect against secondary infection, in a second experiment, RAG1-/- and wild-type mice were injected with a sublethal dose of GBS 48 hours after zymosan injection. Thus, live bacteria were introduced into the inflamed cavity as inflammation resolved, and its effects determined 24 hours later (Figure 2D). Wild-type mice that got zymosan followed by bacteria displayed fewer signs of illness compared with those that received GBS alone, which exhibited 50% mortality by 24 hours, with the remaining animals dying by 48 hours. However, injecting GBS into RAG1-/- mice 48 hours after receiving zymosan showed an approximate doubling of inflammatory cell accumulation compared with wild-type mice treated in the same way (Figure 2D). This resulted in a lower bacterial load in the plasma of GBS-treated RAG1-/- (Figure 2E) but substantially accelerated mortality due to the concomitant hyperinflammatory response (Figure 2F). Results from these studies suggest that inflammation in the resolving phase exerts greater defense against bacterial infection and lethality than do naive tissues. In addition, in terms of controlling initial leukocyte trafficking in response to nonspecific stimuli, protection is conferred by resident lymphocytes, with resistance to secondary infection exerted by repopulating, resolution-phase lymphocytes. Therefore, lymphocytes modulate host responses to injury/infection but are not required to bring about resolution (ie, clear PMNs and macrophages from inflamed sites). The different profile and proportion of lymphocyte repopulating during resolution is necessary to combat secondary infection.
###end p 22
###begin p 23
###xml 0 94 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lymphocytes control early onset of innate inflammation but are dispensable for its resolution.</bold>
###xml 138 141 138 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 448 451 444 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 600 603 596 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 748 751 744 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1116 1117 1112 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1122 1123 1118 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1325 1326 1313 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1338 1339 1324 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1396 1397 1380 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 490 493 <span type="species:ncbi:1319">GBS</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
Lymphocytes control early onset of innate inflammation but are dispensable for its resolution. (A,B) Although inflammation doubled in RAG1-/- during the onset phase in response to zymosan, coincident with (C) an imbalance of IL-10 versus TNFalpha, inflammation normalized with that of wild-type mice from 24 hours onward, suggesting no role for lymphocytes in actively bringing about resolution (ie, clearing PMNs or macrophages). (D) However, RAG1-/- and wild-type mice were injected with GBS during resolution (48 hours after zymosan injection), resulting in enhanced leukocyte accumulation in RAG1-/- but not wild-type mice 24 hours later. (E) This was associated with reduced bacterial colonization in plasma but (F) increased mortality in RAG1-/- mice as a result of the concomitant hyperinflammatory response. We therefore argue that lymphocytes are not required for bringing about resolution and propose that their reappearance hails the end of the inflammatory event and an attempt at restorative physiology. Their role in this setting is in protecting against secondary infection or injury with B cells, CD4+/CD25+ cells, and gamma/delta T cells as well as NK cells playing a likely role in this setting. n = 6 to 8 animals per group, with experiments repeated on 2 separate occasions to confirm original findings. *P </= .05; **P </= .01, as determined by ANOVA, followed by Bonferroni t test, with data expressed as means plus or minus SEM.
###end p 23
###begin title 24
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Peritoneal lymphocytes disappear in response to PGD2 STOPPED
###end title 24
###begin p 25
###xml 127 128 127 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 202 210 202 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 220 221 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 261 262 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 269 270 269 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 271 273 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B18">18</xref></sup>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 341 346 341 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref></sup>
###xml 350 351 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 414 419 410 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12,14</sup>
###xml 423 424 419 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 433 434 429 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 436 438 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 439 441 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 436 441 432 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref></sup>
###xml 460 461 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 473 474 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 572 574 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 572 574 568 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B11">11</xref></sup>
###xml 613 614 609 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 841 843 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 841 843 837 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B11">11</xref></sup>
###xml 870 872 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 873 875 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 870 875 866 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref></sup>
###xml 884 885 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 979 987 975 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1010 1011 1006 1007 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1024 1026 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1024 1026 1020 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B17">17</xref></sup>
###xml 1206 1207 1202 1203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1437 1439 1433 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1437 1439 1433 1435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B23">23</xref></sup>
###xml 1669 1670 1665 1666 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1797 1798 1793 1794 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1799 1802 1795 1798 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2300 2301 2296 2297 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2348 2349 2344 2345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 896 900 <span type="species:ncbi:10090">mice</span>
###xml 1076 1080 <span type="species:ncbi:10090">mice</span>
###xml 1803 1807 <span type="species:ncbi:10090">mice</span>
###xml 2003 2007 <span type="species:ncbi:10090">mice</span>
###xml 2117 2121 <span type="species:ncbi:10090">mice</span>
Investigating how lymphocytes disappear, we recorded equivalent numbers of T and B lymphocytes in the peritoneal cavity of hPGD2S knockout mice at 6 hours as in the naive cavity (0 hours) of wild-type (Figure 3A-E). hPGD2S metabolizes cyclooxygenase-derived PGH2 to PGD2,18 which activates 2 G-protein-coupled receptors, DP1 and DP2 (CRTH2).19,20 PGD2 is further dehydrated to the cyclopentenone PG, 15-deoxy-Delta12,14-PGJ2 (15d-PGJ2),21,22 with levels of PGD2 and 15d-PGJ2 peaking within the first few hours of acute peritonitis coincident with lymphocyte disappearance.11 Incidentally, the existence of 15d-PGJ2 in mammalian systems has been hotly debated over the years, but in these experiments, we used liquid chromatography-mass spectrometry-mass spectrometry (LC-MS-MS) to definitively confirm its presence in resolving inflammation.11 Adding BW245C (DP1 agonist15,16) to hPGD2S knockout mice reduced lymphocytes at 6 hours, with the clearance effects of DP1 on B cells (Figure 3F). 15(R)-15-methyl PGD2 (DP2 agonist17) had no effect on lymphocyte numbers in knockout mice, indicating that DP1 receptor activation is responsible for B-cell disappearance early in acute inflammation. The fate of CD3+ cells remains less clear. For instance, CD3 cells were examined for their adherence to the greater omental lymphoid organ, the so-called leukocyte disappearance reaction typical of peritoneal macrophages during acute peritonitis.23 But, addition of 5% trypsin to a 4-hour inflamed cavity for 10 minutes recovered displaced macrophages but not lymphocytes (Figure S7). Another possibility was that CD3 cells underwent programmed cell death in response to 15d-PGJ2, a highly reactive electrophile and, in our experience, a potent inducer of lymphocyte apoptosis. Although CD3 cells from hPGD2S-/- mice remained low for annexin V/propidium iodide labeling up to 6 hours, on a percentage basis there was a trend toward an increase in annexin V labeling within the equivalent population in wild-type mice. However, this did not reach significance due to the diminished numbers of peritoneal CD3 cells in wild-type mice available for analysis (data not included). Therefore, we can suggest that within a few hours of inducing an inflammatory response, peritoneal resident B cells disappear in a PGD2/DP1-dependent manner, but that the fate of CD3+ cells remains unclear.
###end p 25
###begin p 26
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGD<sub>2</sub> controls the clearance of peritoneal resident lymphocytes.</bold>
###xml 206 207 206 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 362 363 357 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 378 379 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 474 475 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 721 722 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 759 760 752 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
PGD2 controls the clearance of peritoneal resident lymphocytes. In response to inflammatory stimuli, lymphocytes in the peritoneum disappear between 6 and 24 hours. (A-E) However, lymphocyte numbers in hPGD2S knockout mice at 6 hours (■) were found to be equivalent to that present in the naive cavity of wild-type mice (square), suggesting a role for either PGD2 and/or 15d-PGJ2 in the initial clearance of lymphocytes. (F) Adding back BW245C (DP1 receptor agonist) to hPGD2S knockout mice caused a reduction in B cells. Attempts made to identify the fate of CD3 cells generated inconclusive results, with data suggesting that they may die locally by programmed cell death (data not included). n = 8 animals per group. *P </= .05 as determined by Bonferroni t test, with data expressed as means plus or minus SEM.
###end p 26
###begin title 27
Deficiency of repopulating lymphocytes in nonresolving chronic granulomatous disease
###end title 27
###begin p 28
###xml 131 135 131 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 314 319 314 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref></sup>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 747 752 747 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref></sup>
###xml 757 761 757 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 936 944 936 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1081 1085 1081 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1177 1185 1177 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1370 1371 1362 1363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1376 1377 1368 1369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1414 1418 1406 1410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1572 1576 1564 1568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1589 1597 1581 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 327 335 <span type="species:ncbi:9606">patients</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
###xml 1095 1099 <span type="species:ncbi:10090">mice</span>
###xml 1171 1175 <span type="species:ncbi:10090">mice</span>
###xml 1428 1432 <span type="species:ncbi:10090">mice</span>
###xml 1506 1510 <span type="species:ncbi:10090">mice</span>
###xml 1577 1581 <span type="species:ncbi:10090">mice</span>
Finally, the relevance of these findings to human inflammatory diseases was determined by examining the role of lymphocytes in gp91phox knockout mice, an experimental model of human chronic granulomatous disease caused by defects in the phagocyte respiratory burst oxidase, which generates microbicidal superoxide.24,25 Hence, patients with chronic granulomatous disease lack antimicrobial capacity and the ability to combat bacterial and fungal infections. Moreover, there is the associated occurrence of inflammatory granulomas in lung, liver, and skin, which in some instances may arise from sterile stimuli, suggesting that their formation may be due to incomplete degradation of inflammatory debris and/or impaired resolution of inflammation.26,27 gp91phox knockout mice were injected intraperitoneally with sterile zymosan and found to have elevated leukocyte numbers compared with controls, with inflammation failing to resolve (Figure 4A). See also Figure S8 for comparison of cell types in both animals at resolution. Fewer lymphocytes were found at 48 to 96 hours in gp91phox knockout mice, the time frame of resolution and lymphocyte repopulation in wild-type mice (Figure 4B). Lymphocytes obtained from the resolution phase (72 hours) of normal strain-matched wild-type controls which were therefore composed of B1, NK, and gamma/delta T cells as well as CD4+/CD25+ cells, were transferred back to gp91phox knockout mice (72 hours) and challenged with LPS. Inflammation was reduced in knockout mice that received resolution-phase lymphocytes compared with gp91phox mice alone (Figure 4C). These results suggest that during ongoing, nonresolving inflammation, the absence of lymphocytes may account for susceptibility to superinfection and the associated hyperinflammatory response.
###end p 28
###begin p 29
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Absence of repopulating lymphocytes during nonresolving inflammation.</bold>
###xml 129 133 129 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 405 409 405 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 605 606 597 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 611 612 603 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 676 680 668 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 796 800 788 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 876 880 868 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 894 895 886 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 907 908 897 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 964 965 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
###xml 881 885 <span type="species:ncbi:10090">mice</span>
Absence of repopulating lymphocytes during nonresolving inflammation. (A) Zymosan was injected into the peritoneal cavity of pg91phox knockout mice, which, when compared with controls, showed a more aggressive inflammatory response that failed to resolve. (B) FACS analysis of cell types present during resolution revealed a progressive repopulation of lymphocytes during resolution that was lower in pg91phox knockout mice. (C) Lymphocytes obtained from the resolution phase (72 hours) of normal strain-matched wild-type controls and comprising B1 cells, NK cells, and gamma/delta T cells, as well as CD4+/CD25+ cells, were transferred back into the peritoneal cavity of gp91phox knockout mice (72 hours) and subsequently challenged, intraperitoneally, with LPS. Inflammation was reduced in gp91phox knockout mice that received resolution-phase lymphocytes compared with gp91phox mice alone. *P </= .05; **P </= .01 as determined by ANOVA, followed by Bonferroni t test, with data expressed as means plus or minus SEM.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 454 455 454 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 854 855 846 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 935 937 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 935 937 927 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B11">11</xref></sup>
###xml 1012 1015 1004 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 659 662 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 1016 1020 <span type="species:ncbi:10090">mice</span>
Here, evidence is presented that lymphocytes play a pivotal role in controlling the onset of innate immune-mediated inflammation by regulating cytokine synthesis as well as host susceptibility to secondary infection. Analysis of lymphocyte subsets in the naive peritoneal cavity of mice revealed that B cells constitute about 70% to 80% of the total lymphocyte population, of which the majority have a B1 phenotype, with the remainder being B2 cells. CD3+ cells as well as NK and gamma/delta cells make up the remaining 20% of lymphocytes. This profile differs to that found at resolution, which comprises more innate-type lymphocytes and B1 cells expressing MAC-1. Although we did not discern which lymphocyte or combination of lymphocytes bestowed protection at onset or at resolution, in a separate study, peritoneal CD3 T cells and in particular B220+ B cells were found to elaborate high levels of IL-10 in a DP1-dependent manner,11 most likely explaining the reduction in IL-10 in lymphocyte-deficient RAG1-/- mice and subsequent increase in PMN influx in these animals. Thus, given the relative proportion of T cells versus B1 cells in the inflamed cavity and the ability of B cells to synthesis comparatively high levels of IL-10, we suspect that B lymphocytes may one of the predominant cell types modulating acute inflammatory responses to nonspecific stimuli.
###end p 31
###begin p 32
###xml 80 81 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 175 178 175 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 278 279 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 418 419 418 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 695 697 695 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B28">28</xref></sup>
###xml 819 820 819 820 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1181 1182 1181 1182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1242 1244 1242 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1242 1244 1242 1244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B11">11</xref></sup>
###xml 1445 1446 1445 1446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
As PMNs begin to accumulate in response to zymosan, B cells disappeared in a PGD2-dependent manner, as there was equivalent numbers of B cells in the inflamed cavity of hPGD2S-/- at 6 hours as there was in the naive cavity of wild-type mice. This accumulation of B cells in hPGD2S knockout mice was reversed by BW245C, a DP1 receptor agonist, with DP2(CRTH2) playing no role in this setting. While the mechanism of PGD2-dependent B-cell clearance is unknown, a Toll-like receptor (TLR)-mediated transient down-regulation of integrins and CD9 on B1 cells was shown to be required for detachment of these cells from the local peritoneal matrix and their subsequent efflux from the inflamed cavity.28 Whether BW245C alters CD9 expression needs further investigation, but given that B cells disappear concomitantly with PGD2 synthesis, it is possible that DP1 activation may play a role in regulating this pathway of B1 cell detachment and efflux. The fate of CD3 cells, on the other hand, is less clear. While their attachment to the peritoneal lining can certainly be excluded, there is the possibility that these cells may die locally by programmed cell death in response to 15d-PGJ2, which is synthesized concomitant with their disappearance,11 and in our experience, a potent inducer of lymphocyte apoptosis. However, future detailed work is required to definitively identify whether they die locally or clear via draining lymphatics. Thus, PGD2 exerts a dual role on resident B cells at least-regulating their inflammatory cytokine release as well as their efflux from the inflamed peritoneal cavity.
###end p 32
###begin p 33
###xml 529 531 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 529 531 525 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B11">11</xref></sup>
###xml 876 886 872 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 949 952 945 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1033 1035 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1033 1035 1029 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B29">29</xref></sup>
###xml 1208 1210 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1208 1210 1200 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B30">30</xref></sup>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 896 900 <span type="species:ncbi:10090">mice</span>
###xml 953 957 <span type="species:ncbi:10090">mice</span>
The mechanism by which lymphocytes exert their protective effects in these experiments is unclear at this stage. Certainly, there is a cytokine imbalance favoring proinflammatory TNFalpha but reduced IL-10 in the inflamed peritoneum of RAG mice, thereby potentially explaining the enhanced influx of PMNs in these mice compared with wild-type. Indeed, we have shown that both T and B lymphocytes are capable of elaborating inflammatory cytokines, which, on balance, in the inflamed peritoneum at least, serve to limit PMN influx.11 However, in addition to cytokines/chemokines, cell adhesion molecules are also central to facilitating PMN adhesion and accumulation at sites of inflammation and, contrary to data presented here, there is evidence showing that lymphocytes trigger cell adhesion molecule expression. For instance, intracellular adhesion molecule 1 expression in Plasmodium-infected mice is reduced in the brain but not the lung of RAG1-/- mice, while P-selectin expression is attenuated in both organs in these animals.29 Equally, T cells were shown to enhance the expression of TNFalpha-triggered endothelial cell adhesion molecule expression, with these effects varying between vascular beds.30 On this basis, it is difficult to reconcile the role circulating lymphocytes play in up-regulating cell adhesion molecule expression on the leukocyte/endothelial cell interface to that of the resident peritoneal T/B cells other than to highlight the different profile of lymphocytes present in the peritoneum (B1, B2, and small numbers of CD4/CD25 cells) that exert a predominantly protective effect in both the naive and postresolution state.
###end p 33
###begin p 34
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 361 368 361 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref></sup>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 583 583 583 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34"/>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 581 586 581 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B33">33</xref><xref ref-type="bibr" rid="B34"/>&#8211;<xref ref-type="bibr" rid="B35">35</xref></sup>
###xml 933 934 933 934 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
The trigger for lymphocyte repopulation is unclear, but critical determinants of resolution such as PMN apoptosis or signals released by macrophages during phagocytosis of apoptotic leukocytes may play a central role. However, we have shown previously that inducible cyclo-oxygenase is expressed during and is essential for the resolution of acute inflammation,6,31,32 while others have reported that lipoxygenase-lipoxygenase interaction products of arachidonic as well as eicosapentaenoic and docosahexanoic acids dampen the severity of inflammatory onset and trigger resolution.33-35 Taking a closer look at whether cyclo-oxygenase or lipoxygenase play a role in lymphocyte repopulation, we found that not only is COX-2 expressed during the resolution phase of zymosan-induced peritonitis, but that its inhibition with either NS-398 or the nonselective COX inhibitor indomethacin impairs lymphocyte repopulation, in particular CD3+ cells. However, inhibition of lipoxygenase isoforms with baicalein was without effect. These data implicate a COX-2 metabolite in the recruitment of postresolution lymphocytes and therefore protection against host susceptibility to superinfection (J. Newsom, M. Stables, P.C.-N., G.B., and D.W.G., manuscript in preparation).
###end p 34
###begin p 35
###xml 118 119 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 124 125 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 670 673 662 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 915 918 907 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1171 1174 1163 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1296 1304 1288 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1824 1825 1816 1817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 2349 2357 2341 2349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 248 251 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 589 592 <span type="species:ncbi:1319">GBS</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 735 739 <span type="species:ncbi:10090">mice</span>
###xml 774 777 <span type="species:ncbi:1319">GBS</span>
###xml 862 866 <span type="species:ncbi:10090">mice</span>
###xml 877 880 <span type="species:ncbi:1319">GBS</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
###xml 958 961 <span type="species:ncbi:1319">GBS</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
###xml 1175 1179 <span type="species:ncbi:10090">mice</span>
###xml 1263 1267 <span type="species:ncbi:10090">mice</span>
###xml 2304 2307 <span type="species:ncbi:1319">GBS</span>
###xml 2343 2347 <span type="species:ncbi:10090">mice</span>
Comparing repopulating lymphocytes with those in the naive cavity revealed more NK cells, gamma/delta T cells, and CD4+/CD25+ cells, in addition to B1 cells with higher Mac-1 labeling than that found at onset. The functional relevance of increased MAC-1 expression on resolving B1 cells is not apparent at this stage, but may reflect a state of differentiation/activation or a specific requirement for migration back to the resolved peritoneum. However, repopulating lymphocytes have no role in actively bringing about resolution, but protect against superinfection. In these experiments, GBS was given into the resolving peritoneal cavities of wild-type as well as RAG1-/- mice. Interestingly, the degree of inflammation in wild-type mice that received zymosan followed by GBS was not significantly greater than the level of inflammation in resolving wild-type mice not given GBS. In contrast, inflammation in RAG1-/- mice that received zymosan followed by GBS was almost twice that of inoculated wild-type mice. This suggests that resolution-phase lymphocytes confer protection against secondary infection. This was certainly confirmed by injecting live bacteria to RAG-/- mice undergoing resolution, which subsequently died substantially faster than wild-type mice treated in the same manner (Figure 2F). It is unknown why the proportion and profile of repopulating lymphocytes is different to that at onset. Perhaps as resolving tissues are physiologically altered as a consequence of the inflammatory event they underwent, host defense mechanisms need to be fundamentally different to guard against superinfection by recruiting more protective lymphocytes. On this theme, it is not really understood when acutely inflamed tissues revert back to their original state. Certainly, a population of macrophages (about 1 x 106) were found to linger for at least 3 weeks after a zymosan peritonitis apparently resolved, supporting the idea that although the original response was acute and transitory in terms of PMN influx and efflux, its effects may be longer-lasting than originally believed, thereby requiring a different profile and greater proportion of lymphocytes to modulate future inflammatory events. This may explain why inflammation in the resolving phase conferred greater protection against GBS lethality than uninflamed or naive mice (Figure 2D,F).
###end p 35
###begin p 36
###xml 173 177 173 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 246 250 246 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 425 429 425 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 668 677 668 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figures 2</xref>
###xml 679 680 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 819 821 819 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B36">36</xref></sup>
###xml 901 902 901 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 903 904 903 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 901 904 901 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref></sup>
###xml 1081 1083 1081 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1081 1083 1081 1083 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B37">37</xref></sup>
###xml 1154 1156 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1157 1159 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1154 1159 1146 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref></sup>
###xml 1303 1305 1295 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 1303 1305 1295 1297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B40">40</xref></sup>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
Taking these findings to a more clinically relevant setting, it became clear that unlike wild-type mice, there was a deficit of repopulating lymphocytes in nonresolving gp91phox knockout mice bearing zymosan-induced peritonitis. Replenishing gp91phox knockout mice with resolution-phase lymphocytes taken from strain-matched controls and then challenging animals with LPS conferred protection compared with sham-operated gp91phox knockout mice. Data from this study confirm that not only does lymphocyte repopulation fail to occur in nonresolving inflammation, but that resolving-phase lymphocytes protect against exaggerated inflammatory responses to superinfection (Figures 2D,4C). On this note, defects in innate lymphocyte functioning have been suggested to lead to secondary infections associated with burn injury,36 while increased lymphocyte apoptosis contributes to the pathogenesis of sepsis,4,5 underlining the crucial role lymphocytes play in host defense against nonspecific injury. Moreover, as NK cells were originally described for their ability to lyse tumor cells,37 and gamma/delta T cells have well-known tumor surveillance properties,38,39 their absence from sites of nonresolving inflammation may be one of the predisposing factors to the development of inflammation-related cancer.40 Thus, one of the hazards of ongoing acute inflammation and consequently failed lymphocyte repopulation may be increased susceptibility to superinfection and even cancer as a result of lymphocyte apoptosis, lymphocyte immunoparalysis, or, as presented here, a failure of protective lymphocytes to repopulate after resolution.
###end p 36
###begin p 37
###xml 112 120 112 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 234 235 234 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In summary, we report a biphasic role for lymphocytes during innate immune-mediated inflammation, summarized in Figure 5. The first phase controls PMN trafficking with lymphocytes then vacating the peritoneal cavity in response to PGD2 activating its DP1 receptor. The second phase is characterized by lymphocyte repopulation occurring after inflammation begins to resolve in a different proportion and profile to that of the naive state. Importantly, repopulating lymphocytes have no role in bringing about resolution, but protect against secondary infection.
###end p 37
###begin p 38
###xml 0 109 0 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A summary of the scheme of events that occurs in acute inflammation with reference to lymphocyte trafficking.</bold>
A summary of the scheme of events that occurs in acute inflammation with reference to lymphocyte trafficking. As inflammation ensues resident lymphocytes begin to disappear, with B1 cells clearing via draining lymphatics and the fate of CD3 cells remaining unclear at this stage. Once inflammation begins to resolve, lymphocytes repopulate the site of injury in a profile different to that in the naive state.
###end p 38
###begin title 39
Supplementary Material
###end title 39
###begin title 40
[Supplemental Figures]
###end title 40
###begin p 41
The online version of this article contains a data supplement.
###end p 41
###begin p 42
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734.
###end p 42
###begin title 43
Acknowledgments
###end title 43
###begin p 44
###xml 247 248 239 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
The authors would like to acknowledge Dr Tracy Hussell (Kennedy Institute for Rheumatology, London, United Kingdom) for supplying antibodies to NK and gamma/delta T cells and Dr Y. Urade of the Osaka Bioscience Institute (Japan) for supplying hPGD2S knockout mice.
###end p 44
###begin p 45
D.W.G. is a Wellcome Trust funded Career Development Fellow and R.R. is a Kidney Research UK Funded Clinical Research Fellow.
###end p 45
###begin title 46
Authorship
###end title 46
###begin p 47
Contribution: D.W.G. designed research and wrote the paper along with R.R., who carried out the research. T.L., G.B., J.B., and P.C.N. carried out experiments and provided essential experimental material. M.H., D.F., and M.M.Y. supplied essential experimental tools. D.W.G. and P.C.-N. analyzed data.
###end p 47
###begin p 48
Conflict-of-interest disclosure: The authors declare no competing financial interests.
###end p 48
###begin p 49
###xml 195 213 195 213 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d.gilroy@ucl.ac.uk</email>
Correspondence: Derek W. Gilroy, Centre for Clinical Pharmacology and Therapeutics, Division of Medicine, 5 University Street, University College London, London WC1E 6JJ, United Kingdom; e-mail: d.gilroy@ucl.ac.uk.
###end p 49
###begin title 50
References
###end title 50
###begin article-title 51
Inflammatory resolution: new opportunities for drug discovery.
###end article-title 51
###begin article-title 52
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Reduced B cell HLA-DR expression and natural killer cell counts in patients prone to sepsis after injury.
###end article-title 52
###begin article-title 53
Natural killer cells participate in bacterial clearance during septic peritonitis through interactions with macrophages.
###end article-title 53
###begin article-title 54
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte.
###end article-title 54
###begin article-title 55
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Prevention of lymphocyte cell death in sepsis improves survival in mice.
###end article-title 55
###begin article-title 56
###xml 104 107 <span type="species:ncbi:10116">rat</span>
Inducible cyclooxygenase-derived 15-deoxy(Delta)12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis.
###end article-title 56
###begin article-title 57
###xml 42 58 <span type="species:ncbi:562">Escherichia coli</span>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Peritoneal gamma delta T cells induced by Escherichia coli infection in mice: correlation between Thy-1 phenotype and host minor lymphocyte-stimulating phenotype.
###end article-title 57
###begin article-title 58
TRAIL limits excessive host immune responses in bacterial meningitis.
###end article-title 58
###begin article-title 59
IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation.
###end article-title 59
###begin article-title 60
###xml 58 62 <span type="species:ncbi:10116">rats</span>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity.
###end article-title 60
###begin article-title 61
Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxy{Delta}12 14 PGJ2.
###end article-title 61
###begin article-title 62
###xml 123 128 <span type="species:ncbi:9606">human</span>
Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
###end article-title 62
###begin article-title 63
###xml 70 75 <span type="species:ncbi:9606">human</span>
The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering.
###end article-title 63
###begin article-title 64
Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity.
###end article-title 64
###begin article-title 65
###xml 46 51 <span type="species:ncbi:9606">human</span>
Molecular cloning and characterization of the human prostanoid DP receptor.
###end article-title 65
###begin article-title 66
Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues.
###end article-title 66
###begin article-title 67
###xml 84 89 <span type="species:ncbi:9606">human</span>
15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils.
###end article-title 67
###begin article-title 68
Prostaglandin D synthase: structure and function.
###end article-title 68
###begin article-title 69
Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells.
###end article-title 69
###begin article-title 70
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 116 131 <span type="species:ncbi:10090">transgenic mice</span>
Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice.
###end article-title 70
###begin article-title 71
15d-PGJ2: the anti-inflammatory prostaglandin?
###end article-title 71
###begin article-title 72
Cyclopentenone prostaglandins: new insights on biological activities and cellular targets.
###end article-title 72
###begin article-title 73
###xml 118 122 <span type="species:ncbi:10116">rats</span>
Mechanism underlying acute resident leukocyte disappearance induced by immunological and non-immunological stimuli in rats: evidence for a role for the coagulation system.
###end article-title 73
###begin article-title 74
The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH.
###end article-title 74
###begin article-title 75
The respiratory burst oxidase and the molecular genetics of chronic granulomatous disease.
###end article-title 75
###begin article-title 76
Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.
###end article-title 76
###begin article-title 77
NIH conference: recent advances in chronic granulomatous disease.
###end article-title 77
###begin article-title 78
Regulation of B1 cell migration by signals through Toll-like receptors.
###end article-title 78
###begin article-title 79
Regulation of endothelial cell adhesion molecule expression in an experimental model of cerebral malaria.
###end article-title 79
###begin article-title 80
###xml 118 122 <span type="species:ncbi:10090">mice</span>
Lymphocytes mediate TNF-alpha-induced endothelial cell adhesion molecule expression: studies on SCID and RAG-1 mutant mice.
###end article-title 80
###begin article-title 81
A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation.
###end article-title 81
###begin article-title 82
Inducible cyclooxygenase may have anti-inflammatory properties.
###end article-title 82
###begin article-title 83
Lipoxins and new lipid mediators in the resolution of inflammation.
###end article-title 83
###begin article-title 84
Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression.
###end article-title 84
###begin article-title 85
Resolvin E1 and protectin D1 activate inflammation-resolution programmes.
###end article-title 85
###begin article-title 86
Innate lymphocyte subsets and their immunoregulatory roles in burn injury and sepsis.
###end article-title 86
###begin article-title 87
What is a natural killer cell?
###end article-title 87
###begin article-title 88
Immunoregulation in the tissues by gammadelta T cells.
###end article-title 88
###begin article-title 89
Gammadelta T cells: functional plasticity and heterogeneity.
###end article-title 89
###begin article-title 90
A cytokine-mediated link between innate immunity, inflammation, and cancer.
###end article-title 90

